RSV And Mpox Vaccine Added to List of 2024 Immunizations

RSV And Mpox Vaccine Added to List of 2024 Immunizations

The 2024 list of childhood vaccinations will include RSV and Mpox as well. Check out the following reports about this below.

RSV and Mpox added to the list of vaccines

U.S. Centers for Disease Control and Prevention (CDC) suggests that children under the age of 19 months be vaccinated against the respiratory syncytial virus (RSV) and that some young adults be vaccinated against monkeypox (mpox).

“An RSV vaccine, Arexvy, was approved by the U.S. Food and Drug Administration (FDA) in May 2023. It is the first RSV vaccine approved in the United States to prevent the lower respiratory tract disease caused by RSV for people under age 60,” according to the notes.

CDC notes the following on their official website:

“adults 60 years of age and older have the option to receive a single dose of RSV vaccine, based on discussions between the patient and their health care provider. There are two options for protection of infants against RSV: maternal vaccine for the pregnant person and preventive antibodies given to the baby. Only one of these options is needed for most babies to be protected.”

The CDC advises that pregnant individuals receive a single dose of the RSV vaccine between week 32 and week 36 of pregnancy to prevent RSV disease in infants under 6 months of age. For most of the United States, the recommended time for administering the vaccine is from September through January.

However, in certain locations such as Hawaii, Alaska, the territories, and some parts of Florida, the timing of vaccination may vary due to differences in RSV season.

Mpox is spreading in Congo has been severely impacted by EVD, and there are concerns that it could turn into a global epidemic.

To combat the spread of the disease among vulnerable populations, officials have recommended a new vaccine schedule.

The recommendation includes a two-dose series spaced 28 days apart for individuals who identify as gay, bisexual, transgender, or nonbinary and who have met the following criteria in the past six months.

“Been diagnosed with at least one sexually transmitted disease.

Had more than one sex partner.

Had sex at a commercial sex venue.

Had sex in a large public space in an area where mpox transmission is occurring.

The vaccine is not recommended for people under 18 years old.”

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.